Oramed Pharmaceuticals annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2025
Oramed Pharmaceuticals Operating Margin Growth & History (ORMP)
Oramed Pharmaceuticals's operating margin was −754.40% for fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −754.40% | — |
| 2023 | 2023-12-31 | −1,176.79% | +325.17 pp |
| 2022 | 2022-12-31 | −1,501.96% | — |
| 2021 | 2021-08-31 | −896.15% | −462.31 pp |
| 2020 | 2020-08-31 | −433.84% | +107.45 pp |
| 2019 | 2019-08-31 | −541.29% | +11.06 pp |
| 2018 | 2018-08-31 | −552.35% | −113.79 pp |
| 2017 | 2017-08-31 | −438.56% | +1123.06 pp |
| 2016 | 2016-08-31 | −1,561.62% | — |
Oramed Pharmaceuticals quarterly operating margin
Q2.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q3.21
Q3.22
Q1.22
Q1.22
Q2.22
Q3.22
Q3.22
Q4.22
Q1.23
Q2.23
Q1.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −225.00% | — |
| Q2 2023 | 2023-06-30 | −562.46% | +1131.45 pp |
| Q1 2023 | 2023-03-31 | −781.98% | +907.51 pp |
| Q4 2022 | 2022-12-31 | −1,430.25% | +424.53 pp |
| Q3 2022 · Sep 30 | 2022-09-30 | −1,200.73% | −103.23 pp |
| Q3 2022 · Jun 30 | 2022-06-30 | −1,693.92% | −1033.68 pp |
| Q2 2022 | 2022-03-31 | −1,689.49% | −697.90 pp |
| Q1 2022 · Dec 31 | 2021-12-31 | −1,854.78% | −1100.87 pp |
| Q1 2022 · Nov 30 | 2021-11-30 | −1,195.85% | −331.31 pp |
| Q3 2022 · Sep 30 | 2021-09-30 | −1,097.51% | — |
| Q3 2021 · Jun 30 | 2021-06-30 | −660.24% | — |
| Q3 2021 · May 31 | 2021-05-31 | −898.38% | −564.46 pp |
| Q2 2021 · Mar 31 | 2021-03-31 | −991.59% | — |
| Q2 2021 · Feb 28 | 2021-02-28 | −732.03% | −133.07 pp |
| Q1 2021 · Dec 31 | 2020-12-31 | −753.91% | — |
| Q1 2021 · Nov 30 | 2020-11-30 | −864.54% | −504.15 pp |
| Q4 2020 | 2020-08-31 | −443.02% | −98.68 pp |
| Q3 2020 | 2020-05-31 | −333.92% | +264.03 pp |
| Q2 2020 | 2020-02-29 | −598.96% | −63.23 pp |
| Q1 2020 | 2019-11-30 | −360.39% | +328.04 pp |
| Q4 2019 | 2019-08-31 | −344.35% | +166.19 pp |
| Q3 2019 | 2019-05-31 | −597.95% | +136.90 pp |
| Q2 2019 | 2019-02-28 | −535.74% | −20.67 pp |
| Q1 2019 | 2018-11-30 | −688.43% | −241.29 pp |
| Q4 2018 | 2018-08-31 | −510.53% | −48.88 pp |
| Q3 2018 | 2018-05-31 | −734.85% | −385.58 pp |
| Q2 2018 | 2018-02-28 | −515.07% | +35.67 pp |
| Q1 2018 | 2017-11-30 | −447.14% | −54.02 pp |
| Q4 2017 | 2017-08-31 | −461.65% | — |
| Q3 2017 | 2017-05-31 | −349.27% | — |
| Q2 2017 | 2017-02-28 | −550.74% | +978.86 pp |
| Q1 2017 | 2016-11-30 | −393.11% | — |
| Q2 2016 | 2016-02-29 | −1,529.60% | — |
Oramed Pharmaceuticals operating margin trends
Between the periods ended 2016-08-31 and 2025-12-31, Oramed Pharmaceuticals's operating margin increased from −1,561.62% to −754.40%, a change of +807.22 percentage points. The latest reported quarter, Q1 2025, shows −225.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals source filings ↗